ArticleTherapeutic advances in musculoskeletal disease2019

A randomized, phase IIa study to assess the systemic exposure of triamcinolone acetonide following injection of extended-release triamcinolone acetonide or traditional triamcinolone acetonide into both knees of patients with bilateral knee osteoarthritis.

Alan Kivitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.